Woolfelt Pipe Covering (1928–1959)

Manufacturer: GAF Corporation Product Category: Pipe Covering / Thermal Insulation Years Produced: 1928–1959 Legal Tier: Trust Fund Available — GAF Corporation Asbestos Settlement Trust

Product Description

Woolfelt Pipe Covering was a thermal insulation product manufactured by GAF Corporation and sold commercially from 1928 through 1959. Designed to wrap and insulate pipe systems in industrial facilities, the product was marketed for its heat retention properties and its ability to protect workers and equipment from hot pipe surfaces in demanding work environments.

The “Woolfelt” name reflected the product’s composition: a dense, felt-like material engineered to conform to curved pipe surfaces and maintain a tight insulating seal across varying pipe diameters. During the decades in which it was produced, it found widespread application in power generation facilities, manufacturing plants, shipyards, chemical processing operations, and other heavy industrial settings where extensive pipe networks required reliable thermal management.

GAF Corporation, formally known as General Aniline & Film Corporation before adopting the GAF name, operated across multiple product lines during the mid-twentieth century, including roofing materials, floor tiles, and specialty industrial products. Woolfelt Pipe Covering represented one of the company’s offerings in the thermal insulation segment during a period when asbestos was the dominant additive used to improve fire resistance and heat tolerance in industrial materials.

Asbestos Content

Woolfelt Pipe Covering contained asbestos as a core functional component of its composition. Asbestos fibers were incorporated into the felt matrix during manufacturing to enhance the product’s resistance to high temperatures and to reduce the risk of combustion when the covering came into contact with hot pipe surfaces.

Felt-based insulation products of this era commonly relied on chrysotile (white asbestos) and, in some formulations, amphibole asbestos varieties, integrated into fibrous batt and wrap materials. In Woolfelt Pipe Covering, these fibers were bound into the felt structure but were not permanently encapsulated in the way that hard composite materials might contain asbestos. This construction characteristic is significant: felt-based products are generally considered friable materials, meaning the asbestos-containing matrix can be readily crumbled, cut, or abraded under normal handling conditions, releasing respirable fibers into the surrounding air.

Documentation associated with GAF Corporation’s asbestos liabilities, including records underlying the establishment of the GAF Corporation Asbestos Settlement Trust, confirms that pipe covering products produced by the company during this period contained asbestos. The product’s production window of 1928 through 1959 places it squarely within the era of heaviest industrial asbestos use in the United States, predating the regulatory frameworks that would later require asbestos disclosure, substitution, and hazard controls.

How Workers Were Exposed

Industrial workers who handled, installed, maintained, repaired, or removed Woolfelt Pipe Covering faced potential asbestos fiber exposure throughout the product’s service life. Because Woolfelt was a felt-based, friable insulation material, multiple routine work tasks could disturb the asbestos-containing matrix and generate airborne fibers.

Installation: Workers who cut Woolfelt Pipe Covering to fit specific pipe dimensions released asbestos fibers through cutting, trimming, and fitting operations. Pipe systems often required custom lengths and shapes, making cutting a routine and repeated task during installation.

Maintenance and Repair: Insulated pipe systems require periodic inspection and maintenance. Workers who removed sections of Woolfelt Pipe Covering to access valves, fittings, or damaged pipe segments disturbed the aged felt material, which could become increasingly brittle and friable over time, generating substantial fiber release during disturbance.

Removal and Replacement: As Woolfelt Pipe Covering aged, it was often removed entirely and replaced with newer materials. Removal work — particularly on insulation that had been in place for years or decades — could release concentrated quantities of airborne asbestos fibers, especially in enclosed mechanical spaces with limited ventilation.

Bystander Exposure: Workers performing other trades in the same industrial spaces where Woolfelt Pipe Covering was being installed, disturbed, or removed were also exposed to airborne fibers without directly handling the product. In manufacturing plants, boiler rooms, and shipyard spaces, multiple trades frequently worked in close proximity.

The industrial worker population most commonly associated with Woolfelt Pipe Covering exposure includes pipefitters, pipe insulation mechanics (also known as insulators), boilermakers, steamfitters, millwrights, maintenance mechanics, and general laborers assigned to industrial facility work. Because the product was used across multiple industrial sectors, exposure histories vary widely by industry and job site.

Asbestos fibers inhaled or ingested during occupational exposure do not produce immediate symptoms. Diseases associated with asbestos exposure — including mesothelioma, asbestosis, lung cancer, and pleural disease — typically manifest decades after the initial exposure occurred. Workers exposed to Woolfelt Pipe Covering during its production years of 1928 through 1959 may only now be receiving diagnoses of asbestos-related illness.

The GAF Corporation Asbestos Settlement Trust was established to compensate individuals who sustained injuries caused by exposure to asbestos-containing products manufactured or sold by GAF Corporation. Woolfelt Pipe Covering is among the GAF Corporation products documented as asbestos-containing, and individuals with verified exposure to this product may be eligible to file claims with the Trust.

Filing Eligibility

To file a claim with the GAF Corporation Asbestos Settlement Trust, claimants must generally demonstrate:

  • Product exposure: Documentation or affidavit evidence establishing that the claimant was exposed to Woolfelt Pipe Covering or another GAF Corporation asbestos-containing product
  • Diagnosed asbestos-related disease: A qualifying medical diagnosis, which may include mesothelioma, lung cancer, asbestosis, or other asbestos-related conditions recognized under the Trust’s claims criteria
  • Exposure timeline: Evidence that the exposure occurred during a period when the product was manufactured and in use

Typical Claim Categories

Asbestos settlement trusts, including the GAF Corporation Asbestos Settlement Trust, generally recognize multiple disease categories for compensation purposes. Claim categories typically include:

  • Mesothelioma — the highest-priority and typically highest-valued claim category
  • Lung cancer — typically requiring demonstration of occupational asbestos exposure and, in many Trust frameworks, additional qualifying factors
  • Asbestosis and other non-malignant asbestos diseases — including pleural disease and diffuse pleural thickening

Next Steps

Individuals diagnosed with an asbestos-related illness who have a history of occupational exposure to Woolfelt Pipe Covering or other GAF Corporation products should consult an asbestos claims attorney experienced in trust fund filings. Trust claims have specific documentation requirements and deadlines, and legal representation helps ensure that all available compensation sources — including multiple trusts if exposure involved products from more than one manufacturer — are identified and pursued.

Workers, former workers, and in some cases family members of deceased workers may have legal standing to file claims. Wrongful death claims on behalf of individuals who died from asbestos-related disease may also be eligible for consideration under applicable trust and litigation frameworks.

This article is provided for informational purposes. It does not constitute legal advice. Individuals seeking compensation for asbestos-related illness should consult a qualified asbestos litigation attorney.